Search Within

William Douglas Tap

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (55)
  2. Meeting Abstract (44)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (101)
  2. GSK Faculty (101)
  3. Human Oncology and Pathogenesis Program (101)
  4. Sarcoma Service (101)
  5. Solid Tumor Oncology Division (101)
  6. Tow Center for Developmental Oncology (TCDO) (95)

More Groups

People
  1. Ping Chi (69)
  2. Sandra D'Angelo (58)
  3. Mrinal Gounder (57)
  4. Mary Keohan (56)
  5. Mark Dickson (54)
  6. Cristina Antonescu (53)

More People

Years
  1. 2025 (3)
  2. 2024 (12)
  3. 2023 (14)
  4. 2022 (17)
  5. 2021 (5)
  6. 2020 (11)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Clinical Cancer Research (12)
  3. Annals of Oncology (6)
  4. Modern Pathology (4)
  5. Annals of Surgical Oncology (3)
  6. Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. American Association for Cancer Research (19)
  3. Nature Publishing Group (9)
  4. Oxford University Press (8)
  5. Springer (6)
  6. Nature Research (4)

More Publishers

Results (101)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical pharmacokinetics and pharmacodynamics of ivosidenib, an oral, targeted inhibitor of mutant IDH1, in patients with advanced solid tumors
    Journal Article

    Fan, B.; Mellinghoff, I. K.; Wen, P. Y.; Lowery, M. A.; Goyal, L.; Tap, W. D.; Pandya, S. S.; Manyak, E.; Jiang, L.; Liu, G.; more...
    Investigational New Drugs (2020)

    Fulltext@MSK | Save
  • Genomic profiling identifies association of IDH1/IDH2 mutation with longer relapse-free and metastasis-free survival in high-grade chondrosarcoma
    Journal Article

    Zhu, G. G.; Nafa, K.; Agaram, N.; Zehir, A.; Benayed, R.; Sadowska, J.; Borsu, L.; Kelly, C.; Tap, W. D.; Fabbri, N.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • DNA damage response pathway alterations and clinical outcome in leiomyosarcoma
    Meeting Abstract

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Qin, L. X.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Sequenced circulating tumor (ct) DNA to detect the molecular landscape in advanced GIST
    Meeting Abstract

    Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Wheeler, S.; Hasan, M.; Berger, M. F.; Antonescu, C. R.; Tap, W. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Kelly, C. M.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Qin, L. X.; Adamson, T.; Condy, M. M.; Biniakewitz, M.; Phelan, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Koff, A.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Kelly, C. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pilot study of NKTR214 and nivolumab in patients with sarcomas
    Meeting Abstract

    D'Angelo, S. P.; Conley, A. P.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Chi, P.; Keohan, M. L.; Livingston, J. A.; Patel, S.; Adamson, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features and outcomes of secondary somatic malignancy (SSM) arising from teratoma in late relapse germ cell tumor (GCT)
    Meeting Abstract

    Wong, N. C.; Dason, S.; Dean, L. W.; Isharwal, S.; Donoghue, M.; Jia, L.; Joseph, G.; Tap, W. D.; Funt, S. A.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT)
    Meeting Abstract

    Dean, L. W.; Wong, N. C.; Dason, S.; Isharwal, S.; Donoghue, M.; Jia, L.; Tap, W. D.; Joseph, G.; Funt, S. A.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of binimetinib (MEK162) combined with pexidartinib (PLX3397) in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Rosenbaum, E.; Kelly, C.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; Movva, S.; Condy, M.; Adamson, T.; Mcfadyen, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save